Recurrent pyoderma in a family with a defect in leucocyte locomotion

Autor Zielinski, C C, Dremsek, P A, Eibl, Martha M
Vydáno 1985

Modulation of leucocyte locomotion by interleukin-1.

Autor Zielinski, C C, Pesau, B, Kalinowski, W, Müller, C
Vydáno 1990

Functional activity of peripheral mononuclear cells in cystic fibrosis: antibodies and plaque formation.

Autor Götz, M, Zielinski, C C, Ahmad, R, Eibl, M
Vydáno 1982

Divergent patterns of leucocyte locomotion in experimental post-traumatic osteomyelitis.

Autor Müller, C., Zielinski, C. C., Passl, R., Eibl, M. M.
Vydáno 1984

Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy.

Autor Zielinski, C. C., Müller, C., Tichatschek, E., Aiginger, P.
Vydáno 1989

Recurrent pyoderma in a family with a defect in leucocyte locomotion.

Autor Zielinski, C C, Dremsek, P A, Ahmad, R, Eibl, M M
Vydáno 1984

Plaque-forming cells in human cord blood: studies on T and B cell function.

Autor Eibl, M, Zielinski, C C, Ahmad, R, Steurer, F, Rockenschaub, A
Vydáno 1980

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.

Autor Zielinski, C. C., Schnack, B., Grbovic, M., Brodowicz, T., Wiltschke, C., Steger, G., Pflüger, H., Marberger, M.
Vydáno 1998

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable

Autor Vogl, U M, Zehetgruber, H, Dominkus, M, Hejna, M, Zielinski, C C, Haitel, A, Schmidinger, M
Vydáno 2006

Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-α and retinoids

Autor Brodowicz, T, Wiltschke, C, Kandioler-Eckersberger, D, Grunt, T W, Rudas, M, Schneider, S M, Hejna, M, Budinsky, A, Zielinski, C C
Vydáno 1999

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status

Autor Brodowicz, T, Kandioler, D, Tomek, S, Ludwig, C, Rudas, M, Kunstfeld, R, Koestler, W, Hejna, M, Budinsky, A, Wiltschke, C, Zielinski, C C
Vydáno 2001

P04.03 Analysis of the inflammatory tumor microenvironment in meningeal malignancies

Autor Berghoff, A. S., Kresl, P., Rajky, O., Widhalm, G., Ricken, G., Hainfellner, J., Marosi, C., Zielinski, C. C., Birner, P., Preusser, M.
Vydáno v Neuro Oncol (2016)

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center

Autor Füreder, L. M., Widhalm, G., Gatterbauer, B., Dieckmann, K., Hainfellner, J. A., Bartsch, R., Zielinski, C. C., Preusser, M., Berghoff, A. S.
Vydáno v Clin Exp Metastasis (2018)

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Autor Wiltschke, C., Krainer, M., Budinsky, A. C., Berger, A., Müller, C., Zeillinger, R., Speiser, P., Kubista, E., Eibl, M., Zielinski, C. C.
Vydáno 1995

P08.01 RESPONSE TO T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BM)

Autor Berghoff, A.S., Bartsch, R., Bergen, E., Rudas, M., Gnant, M., Dieckmann, K., Pinker, K., Zielinski, C.C., Steger, G.G., Preusser, M.
Vydáno 2014

HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens.

Autor Smolen, J S, Klippel, J H, Penner, E, Reichlin, M, Steinberg, A D, Chused, T M, Scherak, O, Graninger, W, Hartter, E, Zielinski, C C
Vydáno 1987

OS7.4 Outcome of patients presenting with brain metastasis as first manifestation of cancer

Autor Füreder, L. M., Berghoff, A. S., Gatterbauer, B., Dieckmann, K., Widhalm, G., Hainfellner, J. A., Birner, P., Bartsch, R., Zielinski, C. C., Preusser, M.
Vydáno v Neuro Oncol (2016)

Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatm...

Autor Hudelist, G, Köstler, W J, Attems, J, Czerwenka, K, Müller, R, Manavi, M, Steger, G G, Kubista, E, Zielinski, C C, Singer, C F
Vydáno 2003

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors

Autor Berghoff, A S, Bago-Horvath, Z, Ilhan-Mutlu, A, Magerle, M, Dieckmann, K, Marosi, C, Birner, P, Widhalm, G, Steger, G G, Zielinski, C C, Bartsch, R, Preusser, M
Vydáno 2012

Prognostic impact of breast cancer subtypes in elderly patients

Autor Bergen, E. S., Tichy, C., Berghoff, A. S., Rudas, M., Dubsky, P., Bago-Horvath, Z., Mader, R. M., Exner, R., Gnant, M., Zielinski, C. C., Steger, G. G., Preusser, M., Bartsch, R.
Vydáno v Breast Cancer Res Treat (2016)